drugset / Trial / NCT01882621
Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients
RandomizedSingle-groupTriple-blindTreatment
Summary
Evaluate the efficacy and safety of Monosialoganglioside(GM1) to prevent the neurotoxicity induced by cisplatin
Timeline
- Start
- 2013-10
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Monosialoganglioside GM1 | Unknown | 80 mg | Intravenous |